Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma
Clinical trial NCT06705725 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06705725
- Sponsor
- Carbiogene Therapeutics Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-26
- Primary completion
- 2027-10-25
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.